Routine Plasma Anti-Xa Monitoring is Required for Low-Molecular-Weight Heparins

By Al-Sallami Hesham S.  

Clinical Pharmacokinetics, Vol. 49, Iss. 9, 2010-09 ,pp. : 567-571

Adis International

Access to resources Recommend Favorite

Synthesis and Anticoagulant Activity of Low-Molecular-Weight Heparins

By Stolbushkina P. P.   Bannikova G. E.   Drozd N. N.   Makarov V. A.   Varlamov V. P.   Vikhoreva G. A.  

Pharmaceutical Chemistry Journal, Vol. 38, Iss. 2, 2004-02 ,pp. : 82-85

Springer Publishing Company

Access to resources Recommend Favorite

Low molecular weight heparins

By Aguilar O.M.   Kleiman N.S.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 6, 2000-09 ,pp. : 1091-1103

Informa Healthcare

Access to resources Recommend Favorite

Use of Low-Molecular-Weight Heparins and New Anticoagulants in Elderly Patients with Renal Impairment

By >  

Drugs & Aging, Vol. 28, Iss. 3, 2011-03 ,pp. : 177-193

Adis International

Access to resources Recommend Favorite

Comparison of Anti-Xa Activity After a Single Intravenous Bolus of Low-dose Enoxaparin in Patients With and Without End-stage Renal Disease

By Lin J-S   Wang W-J   Lin W-C   Wu X-M   Chao C-L  

The Journal of International Medical Research, Vol. 37, Iss. 6, 2009-11 ,pp. : 1890-1896

Field House Publishing

Access to resources Recommend Favorite